BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Company Screener
M&A Activity
Historical M&A Data
M&A Target Ideas
Meeting Calendar
Hedge Funds
Analysts & Portfolios

My WatchlistsMy Notes
Try Pro FreeAlready have an account? Login

Enterprise Value

634.1M

Cash

58.32M

Avg Qtr Burn

-43.89M

Short % of Float

20.03%

Insider Ownership

1.44%

Institutional Own.

25.90%

Qtr Updated

09/30/22


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Rucaparib (Rubraca®) Details
Prostate cancer, Cancer

Approved

Quarterly sales

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rucaparib (Rubraca®) Details
Cancer, Prostate cancer

Phase 3

Data readout

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rucaparib (Rubraca®) Details
Ovarian cancer, Cancer

Phase 3

Data readout

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.